GRCE
Grace Therapeutics, Inc. Common Stock
GRCE
GRCE
14 hedge funds and large institutions have $2.55M invested in Grace Therapeutics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$63K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$27K |
| 3 |
Renaissance Technologies
New York
|
+$25K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$24K |
| 5 |
PVI
Pura Vida Investments
New York
|
+$20.2K |
